Physician profile
Ryan Moore
NPI 1235541350
$9,606.39
in general payments reported to CMS, 2019-2025
15 companies · $5,679 in 2025
The $5,679 reported for 2025 was more than what 89% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.00 · 2022: $2,441 · 2023: $156 · 2024: $1,311 · 2025: $5,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,628 · Education: $2,500 · Food and Beverage: $2,010 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,627.69 |
| Education | $2,500.00 |
| Food and Beverage | $2,009.79 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,470.42 | 2020-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $315.98 | 2022-2025 | Signia, Ligasure, Eea |
| Acera Surgical, INC. | $171.77 | 2024-2025 | Restrata Wound Matrix |
| Ethicon US, LLC | $169.37 | 2022 | |
| Ambu INC. | $110.20 | 2025 | |
| Thd America, INC. | $80.47 | 2022-2025 | |
| Celltrion USA INC. | $71.98 | 2025 | Vegzelma |
| Tela Bio, INC. | $48.75 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Aimmune Therapeutics, INC. | $35.95 | 2025 | Vowst |
| Braintree Laboratories, INC. | $31.06 | 2025 | Suflave |
| Davol INC. | $25.36 | 2023 | Phasix Mesh |
| Mimedx Group, INC. | $22.56 | 2025 | |
| Sanara Medtech INC. | $22.08 | 2025 | Biasurge |
| Takeda Pharmaceuticals U.S.A., INC. | $16.05 | 2024 | Gattex |
| Mesh Suture INC | $14.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.